Times Square Capital Management, LLC Adaptive Biotechnologies Corp Transaction History

Times Square Capital Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$6.4 - $14.73 $5.05 Million - $11.6 Million	-788,585 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$10.12 - $28.9 $2.28 Million - $6.52 Million	-225,600 Reduced 22.24%	788,585 $10.9 Million
Q4 2021 Feb 04, 2022	SELL	$25.17 - $36.85 $1.41 Million - $2.07 Million	-56,100 Reduced 5.24%	1,014,185 $28.5 Million
Q3 2021 Nov 08, 2021	SELL	$30.02 - $39.87 $276,184 - $366,804	-9,200 Reduced 0.85%	1,070,285 $36.4 Million
Q2 2021 Aug 09, 2021	SELL	$32.22 - $44.59 $1.17 Million - $1.62 Million	-36,400 Reduced 3.26%	1,079,485 $44.1 Million
Q1 2021 May 12, 2021	SELL	$37.26 - $67.74 $9.4 Million - $17.1 Million	-252,178 Reduced 18.43%	1,115,885 $44.9 Million
Q4 2020 Feb 12, 2021	SELL	$45.01 - $65.47 $3.64 Million - $5.29 Million	-80,800 Reduced 5.58%	1,368,063 $80.9 Million
Q3 2020 Nov 06, 2020	SELL	$35.79 - $48.81 $4.51 Million - $6.15 Million	-126,027 Reduced 8.0%	1,448,863 $70.5 Million
Q2 2020 Aug 07, 2020	SELL	$24.95 - $48.38 $2.51 Million - $4.87 Million	-100,700 Reduced 6.01%	1,574,890 $76.2 Million
Q1 2020 May 08, 2020	BUY	$16.96 - $34.16 $3.13 Million - $6.31 Million	184,709 Added 12.39%	1,675,590 $46.5 Million
Q4 2019 Feb 05, 2020	BUY	$24.56 - $32.8 $9.54 Million - $12.7 Million	388,560 Added 35.25%	1,490,881 $44.6 Million
Q3 2019 Nov 05, 2019	BUY	$30.31 - $53.51 $19.8 Million - $34.9 Million	651,621 Added 144.58%	1,102,321 $34.1 Million
Q2 2019 Aug 02, 2019	BUY	$40.3 - $48.3 $18.2 Million - $21.8 Million	450,700 New	450,700 $21.8 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $812M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.